Form 8-K

8-K — HAWKINS INC

Accession: 0000046250-26-000017

Filed: 2026-05-13

Period: 2026-05-13

CIK: 0000046250

SIC: 5160 (WHOLESALE-CHEMICALS & ALLIED PRODUCTS)

Item: Results of Operations and Financial Condition

Documents

8-K — hwkn-20260513.htm (Primary)

EX-99.1 (hwknex9912026-q4.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: hwkn-20260513.htm · Sequence: 1

hwkn-20260513

0000046250FALSE00000462502026-05-132026-05-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 13, 2026

Hawkins, Inc.

(Exact name of registrant as specified in its charter)

Minnesota 0-7647 41-0771293

(State of Incorporation) (Commission File Number) (IRS Employer Identification No.)

2381 Rosegate, Roseville, MN 55113

(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code (612) 331-6910

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $.01 per share

HWKN

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b 2).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02. Results of Operations and Financial Condition.

On May 13, 2026, Hawkins, Inc. issued a press release announcing financial results for its fourth quarter and fiscal year ended March 29, 2026. A copy of the press release issued by the Registrant is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits.

Exhibit No. Description Method of Filing

99.1

Press Release, dated May 13, 2026, announcing financial results of Hawkins, Inc. for its fourth quarter and fiscal year ended March 29, 2026.

Filed Electronically

104 Cover Page Interactive Data File (embedded within the inline XBRL document) Filed Electronically

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HAWKINS, INC.

Date: May 13, 2026

By: /s/ Jeffrey P. Oldenkamp

Jeffrey P. Oldenkamp

Executive Vice President and Chief Financial Officer

EX-99.1

Filename: hwknex9912026-q4.htm · Sequence: 2

Document

Exhibit 99.1

May 13, 2026

Hawkins, Inc.

2381 Rosegate

Roseville, MN 55113

Hawkins, Inc. Reports

Fourth Quarter and Fiscal Year 2026 Results

ROSEVILLE, Minn., May 13, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 29, 2026.

Fourth Quarter Fiscal Year 2026 Highlights:

•Record fourth quarter sales of $265.9 million, an 8% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 16% over the same quarter in the prior year. All segments grew revenue in the fourth quarter 2026.

•Record fourth quarter gross profit of $54.2 million, a 4% increase over the same quarter of the prior year.

•Fourth quarter diluted earnings per share (EPS) of $0.74, a decrease of $0.04, or 5%, due primarily to an approximately $4.4 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed in fiscal 2026, including the largest, WaterSurplus, which closed in the first quarter of fiscal 2026. Assuming the acquisition of WaterSurplus had occurred at the beginning of the prior fiscal year, pro forma EPS would have been 9% higher than the comparable prior year.

•Fourth quarter operating cash flow of $37.7 million, an increase of $6.9 million, or 22% over the same quarter in the prior year.

Full-Year Fiscal Year 2026 Highlights:

•Sales of approximately $1.1 billion, an increase of $109.3 million, or 11% from fiscal 2025.

•Gross profit of $245.1 million, an increase of $19.5 million, or 9% from fiscal 2025.

•Operating cash flow of $144.3 million, an increase of $33.2 million, or 30% from fiscal 2025.

•Diluted earnings per share (EPS) of $3.91, a decrease of $0.12, or 3%, from fiscal 2025, due primarily to an approximately $16.5 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed in fiscal 2026, including WaterSurplus. Assuming the acquisition of WaterSurplus had occurred at the beginning of the prior fiscal year, pro forma EPS would have increased by $0.32, or 9%, over the prior fiscal year.

•Net income was $81.5 million, while Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (Adjusted EBITDA), a non-GAAP measure, was $179.0 million, an increase of 6% over the prior fiscal year.

•Continued our acquisitions strategy and closed on six transactions during the fiscal year, mainly focused on accelerating growth in the Water Treatment segment.

•Paid cash dividends of $0.75 per share for the year, an increase of 7% over the prior year, marking our 41st consecutive year of paying a dividend.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Fiscal 2026 was another milestone year for our company, as we crossed $1 billion in revenue, for the first time in our history. My thanks to every person connected to our great company for helping us accomplish this goal. This achievement resulted in a number of records for the year; including sales, gross margin, operating income, and adjusted EBITDA. Our focus has long been to deliver sustained growth over time, and we have continued to execute on that with pro forma EPS growth for the eighth consecutive year."

Mr. Hawkins continued, "Our disciplined M&A strategy remained a core competency for us and has again contributed to growth of Water Treatment, our largest reporting segment, which now represents 50% of our total company revenue and 56% of the total company operating income. We have completed 17 acquisitions over the last five years, most of which have helped to drive accelerated growth in our Water Treatment segment and we expect future acquisitions to continue to be focused on Water Treatment. With our latest deals, we now have a full product portfolio for our Water Treatment customers, including chemicals, media and filtration products, and equipment."

Mr. Hawkins continued, “Our Water Treatment segment achieved sales growth of 22% for the year, through sales from our acquired companies as well as organic growth. Sales in our Food and Health Sciences segment were relatively flat, mainly due to softness in the food and nutrition end markets, and our Industrial Solutions segment was up 6% for the year."

Mr. Hawkins concluded, “Looking ahead to fiscal 2027, we are well positioned to grow revenue and operating income in each of our business segments and expect EPS to grow as well. We expect our balance sheet to remain strong, and with the diversity of our businesses and the overall strength of our company, we believe we will continue to generate strong operating cash flow. This will allow us to fund future growth investments and continue to pay down our debt during fiscal year 2027 as we expect to achieve a leverage ratio of approximately 1x adjusted EBITDA by the end of fiscal year 2027.”

Fourth Quarter and Fiscal Year Financial Highlights:

NET INCOME

For the fourth quarter of fiscal 2026, the company reported net income of $15.5 million, or $0.74 per diluted share, compared to net income for the fourth quarter of fiscal 2025 of $16.3 million, or $0.78 per diluted share.

For the full year, the Company reported record net income of $81.5 million, or $3.91 per diluted share, compared to net income for fiscal 2025 of $84.3 million, or $4.03 per diluted share.

REVENUE

For the fourth quarter of fiscal 2026, sales were $265.9 million, an increase of $20.6 million, or 8%, from sales of $245.3 million a year ago. Each of our segments contributed to the year-over-year growth, with our Water Treatment segment leading the way with 16% growth. Water Treatment segment sales increased $17.3 million, or 16%, to $122.3 million for the fourth quarter, as compared to $105.0 million for the same period a year ago. Sales increased primarily as a result of $13.1 million of added sales from acquired businesses as well as increased sales volumes in our legacy business. Food and Health Sciences segment sales increased $0.3 million, or less than 1%, to $88.6 million for the fourth quarter, as compared to $88.3 million for the same period a year ago. Sales increased slightly with increased volumes of our Agricultural products, mostly offset by lower selling prices. Industrial Solutions segment sales increased $3.0 million, or 6%, to $55.0 million for the fourth quarter, as compared to $52.0 million for the same period a year ago. Sales increased primarily as a result of increased sales of certain of our manufactured, blended and repackaged products.

For fiscal 2026, sales were $1,083.7 million, an increase of $109.3 million, or 11%, from sales of $974.4 million a year ago. Water Treatment segment sales were $543.3 million for the year, an increase of 22% over last year’s sales of $446.5 million; of the $96.8 million increase, $83.3 million was from our acquired businesses in fiscal 2026. Sales for our Food and Health Sciences segment were $320.7 million in fiscal 2026, a decrease of 1%, from fiscal 2025 sales of $322.6 million. Industrial Solutions segment sales were $219.7 million, an increase of 7% from fiscal 2025 sales of $205.4 million.

GROSS PROFIT

Gross profit for fiscal 2026 increased $19.5 million, or 9%, to $245.1 million, or 23% of sales, from $225.5 million, or 23% of sales, for fiscal 2025. During fiscal 2026, the LIFO reserve increased, and gross profits decreased, by $1.5 million, of which $0.8 million occurred in the fourth quarter, primarily due to rising material costs. During fiscal 2025, the LIFO reserve decreased, and gross profit increased, by $1.6 million, most of which occurred in the fourth quarter. Gross profit increased due to increased sales, partially offset by the unfavorable year-over-year impact of the increased LIFO reserve.

Gross profit for the Water Treatment segment increased $23.2 million, or 19%, to $145.0 million, or 27% of sales, for fiscal 2026, from $121.8 million, or 27% of sales, for fiscal 2025. Gross profit increased as a result of the increased sales.

Gross profit for our Food and Health Sciences segment decreased $4.6 million, or 6%, to $67.3 million, or 21% of sales, for fiscal 2026, from $71.9 million, or 22% of sales, for fiscal 2025. Gross profit decreased as a result of lower selling prices as a result of competitive pricing pressures.

Gross profit for the Industrial Solutions segment increased $1.0 million, or 3%, to $32.8 million, or 15% of sales, for fiscal 2026, from $31.8 million, or 15% of sales, for fiscal 2025. Gross profit increased as a result of the increase in sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

SG&A expenses increased $17.4 million, or 16%, to $123.8 million, or 11% of sales, for fiscal 2026, from $106.4 million, or 11% of sales, for fiscal 2025. Expenses increased largely due to $19.3 million in added costs from the acquired business in our Water Treatment segment, including amortization of intangibles of $8.9 million, fair value accretion on the WaterSurplus earnout liability of $1.9 million, as well as increased variable costs. This was partially offset by a reduction of $8.1 million to the Water Solutions earnout.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended March 29, 2026, was $37.2 million, an increase of $0.2 million, or 1%, from adjusted EBITDA of $37.0 million for the same period in the prior year. Full-year adjusted EBITDA was $179.0 million, an increase of $10.2 million, or 6%, from adjusted EBITDA of $168.9 million for fiscal 2025. The increase was due to the impact of improved gross profits discussed above.

INCOME TAXES

Our effective tax rate was approximately 25% for fiscal 2026 and 26% for fiscal 2025. The current year decrease in the effective tax rate was primarily driven by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. For fiscal 2027, we expect the income tax rate to be between 25% to 27%.

BALANCE SHEET

Our operating cash flow of $144.3 million and net debt borrowings during the fiscal year of $95.0 million were primarily used to grow the company, fund acquisitions, and provide shareholder return. This included funding $167.1 million in acquisition spending for acquisitions of WaterSurplus, Inc. and five additional smaller tuck-in acquisitions, capital spending of $58.2 million, and dividend payments of $15.7 million. Our total debt outstanding at the end of fiscal 2026 was $244.0 million and our leverage ratio was 1.37x our trailing twelve-month pro forma adjusted EBITDA, as compared to 0.86x at the end of fiscal 2025.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 66 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and has approximately 1,200 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA and return on equity. These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses these non-GAAP financial measures internally to understand, manage and evaluate our business and to make operating decisions. Management believes that these non-GAAP financial measures reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation, and charges for the employee stock purchase plan and restricted stock grants, non-recurring items of income or expense, and non-cash earnout related expense. The non-cash earnout related expense adjustment is a new adjustment which was made to better reflect results from operations.

Adjusted EBITDA Three Months Ended Fiscal Year Ended

(In thousands) March 29, 2026 March 30, 2025 March 29, 2026 March 30, 2025

Net income (GAAP) $ 15,463 $ 16,327 $ 81,548 $ 84,345

Interest expense, net 2,972 1,526 13,507 5,432

Income tax expense 4,461 6,095 27,792 30,038

Amortization of intangibles 5,494 3,553 21,292 12,764

Depreciation expense 8,085 7,027 31,250 27,184

Non-cash compensation expense 2,135 1,476 8,573 6,498

Non-recurring acquisition expense 18 649 1,239 1,229

Non-cash earnout related expense $ (1,410) $ 342 $ (6,177) $ 1,375

Adjusted EBITDA $ 37,218 $ 36,995 $ 179,024 $ 168,865

Beginning with the Q4 and fiscal 2026 earnings release, we are including a return on equity. We define return on equity as net income divided by average shareholders' equity.

Return on Equity

($ in thousands)

Fiscal Year Ended

March 29, 2026

Net income (GAAP) $ 81,548

Shareholders' equity at beginning of period $ 460,292

Shareholders' equity at end of period 534,009

Average shareholders' equity $ 497,151

Return on equity 16.4 %

HAWKINS, INC.

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

(In thousands, except share and per-share data)

Three Months Ended Fiscal Year Ended

March 29, 2026 March 30, 2025 March 29, 2026 March 30, 2025

(unaudited)

Sales $ 265,910 $ 245,318 $ 1,083,696 $ 974,431

Cost of sales (211,673) (193,081) (838,641) (748,893)

Gross profit 54,237 52,237 245,055 225,538

Selling, general and administrative expenses (30,773) (27,662) (123,762) (106,364)

Operating income 23,464 24,575 121,293 119,174

Interest expense, net (2,972) (1,526) (13,507) (5,432)

Other income (expense) (568) (627) 1,554 641

Income before income taxes 19,924 22,422 109,340 114,383

Income tax expense (4,461) (6,095) (27,792) (30,038)

Net income $ 15,463 $ 16,327 $ 81,548 $ 84,345

Weighted average number of shares outstanding-basic 20,751,747 20,728,528 20,736,815 20,803,872

Weighted average number of shares outstanding-diluted 20,870,810 20,848,118 20,861,860 20,936,502

Basic earnings per share $ 0.75 $ 0.79 $ 3.93 $ 4.05

Diluted earnings per share $ 0.74 $ 0.78 $ 3.91 $ 4.03

HAWKINS, INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(In thousands, except share and per-share data)

March 29, 2026 March 30, 2025

ASSETS

CURRENT ASSETS:

Cash and cash equivalents $ 3,914 $ 5,103

Trade accounts receivables, net 139,796 131,795

Inventories 78,199 83,512

Income taxes receivable 891 2,864

Prepaid expenses and other current assets 8,665 7,417

Total current assets 231,465 230,691

PROPERTY, PLANT, AND EQUIPMENT:

Land 21,223 18,679

Buildings and improvements 193,210 163,913

Machinery and equipment 175,495 150,981

Transportation equipment 89,220 78,064

Office furniture and equipment 10,514 9,316

489,662 420,953

Less accumulated depreciation 223,406 195,667

Net property, plant, and equipment 266,256 225,286

OTHER ASSETS:

Right-of-use assets 16,840 13,449

Goodwill 223,042 135,409

Intangible assets, net 232,887 150,121

Deferred compensation plan assets 12,812 11,185

Other assets 2,988 3,907

Total other assets 488,569 314,071

Total assets $ 986,290 $ 770,048

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Accounts payable — trade $ 59,835 $ 61,195

Accrued payroll and employee benefits 20,092 19,659

Short-term lease liabilities 3,000 2,900

Contract liability 1,580 —

Accrued real estate taxes 1,224 1,030

Current portion of deferred compensation liability 1,334 538

Container deposits 1,383 1,914

Current portion of earnout liability 4,529 —

Environmental remediation 7,700 7,700

Other current liabilities 4,167 2,286

Total current liabilities 104,844 97,222

March 29, 2026 March 30, 2025

LONG-TERM LIABILITIES:

Long-term debt 244,000 149,000

Long-term lease liabilities 14,457 10,920

Pension withdrawal liability 2,763 3,155

Deferred income taxes 25,110 22,356

Deferred compensation liability 14,850 13,132

Earnout liability 44,898 12,604

Other long-term liabilities 1,359 1,367

Total long-term liabilities 347,437 212,534

Total liabilities 452,281 309,756

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS’ EQUITY:

Common shares; authorized: 60,000,000 shares of $0.01 par value; 20,752,138 and 20,684,621 shares issued and outstanding for 2026 and 2025, respectively 208 207

Additional paid-in capital 32,678 24,094

Retained earnings 500,142 434,259

Accumulated other comprehensive income 981 1,732

Total shareholders’ equity 534,009 460,292

Total liabilities and shareholders’ equity $ 986,290 $ 770,048

HAWKINS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)

Fiscal Year Ended

March 29, 2026 March 30, 2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income $ 81,548 $ 84,345

Reconciliation to cash flows:

Depreciation and amortization 52,542 39,948

Change in fair value of earnout liability (6,177) 1,369

Operating leases 3,982 3,475

Gain on deferred compensation assets (1,554) (641)

Deferred income taxes 3,053 461

Stock compensation expense 8,573 6,498

Gain from asset disposals (202) (61)

Other, net 179 87

Changes in operating accounts (using) providing cash, net of acquisitions:

Trade receivables (2,467) (11,230)

Inventories 10,053 (6,572)

Accounts payable (5,841) 2,445

Accrued liabilities 2,195 476

Lease liabilities (3,775) (3,468)

Income taxes 2,071 (4,807)

Other, net 147 (1,229)

Net cash provided by operating activities 144,327 111,096

CASH FLOWS FROM INVESTING ACTIVITIES:

Additions to property, plant, and equipment (58,239) (41,096)

Acquisitions (167,108) (87,400)

Proceeds from asset disposals 1,248 544

Net cash used in investing activities (224,099) (127,952)

CASH FLOWS FROM FINANCING ACTIVITIES:

Cash dividends paid (15,665) (14,635)

ESPP shares issued 3,040 2,658

Shares surrendered for payroll taxes (3,028) (2,541)

Shares repurchased — (20,676)

Payments for debt issuance costs (764) —

Payments on senior secured revolving loan (75,000) (60,000)

Borrowings on senior secured revolving loan 170,000 110,000

Net cash provided by (used in) financing activities 78,583 14,806

NET DECREASE IN CASH AND CASH EQUIVALENTS (1,189) (2,050)

CASH AND CASH EQUIVALENTS - beginning of year 5,103 7,153

CASH AND CASH EQUIVALENTS - end of year $ 3,914 $ 5,103

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION-

Cash paid during the year for income taxes, net of refunds $ 22,685 $ 34,386

Cash paid for interest 13,650 5,785

Noncash investing activities - Capital expenditures in accounts payable 2,536 1,841

HAWKINS, INC.

REPORTABLE SEGMENTS (UNAUDITED)

(In thousands)

Water

Treatment Food and Health Sciences Industrial Solutions Total

Fiscal Year Ended March 29, 2026:

Sales $ 543,303 $ 320,700 $ 219,693 $ 1,083,696

Cost of sales - materials ( 327,821 ) ( 233,960 ) ( 174,415 ) ( 736,196 )

Cost of sales - operational overhead ( 70,529 ) ( 19,408 ) ( 12,508 ) ( 102,445 )

Gross profit 144,953 67,332 32,770 245,055

Selling, general, and administrative expenses ( 76,865 ) ( 32,981 ) ( 13,916 ) ( 123,762 )

Operating income $ 68,088 $ 34,351 $ 18,854 $ 121,293

Fiscal Year Ended March 30, 2025:

Sales $ 446,489 $ 322,560 $ 205,382 $ 974,431

Cost of sales - materials ( 259,722 ) ( 231,621 ) ( 160,199 ) ( 651,542 )

Cost of sales - operational overhead ( 64,934 ) ( 19,021 ) ( 13,396 ) ( 97,351 )

Gross profit 121,833 71,918 31,787 225,538

Selling, general, and administrative expenses ( 62,287 ) ( 30,720 ) ( 13,357 ) ( 106,364 )

Operating income $ 59,546 $ 41,198 $ 18,430 $ 119,174

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “estimate,” “can,” “could,” “expect,” “intend,” “plan,” “may,” “predict,” “should,” ”would,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, changes in product supplies, the availability of target acquisitions, and changes in interest rates. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 30, 2025, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts: Jeffrey P. Oldenkamp

Executive Vice President and Chief Financial Officer

612/331-6910

ir@HawkinsInc.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

May 13, 2026

Cover [Abstract]

Document Type

8-K

Document Period End Date

May 13, 2026

Entity Registrant Name

Hawkins, Inc.

Entity Incorporation, State or Country Code

Entity File Number

0-7647

Entity Tax Identification Number

41-0771293

Entity Address, Address Line One

2381 Rosegate,

Entity Address, City or Town

Roseville,

Entity Address, State or Province

Entity Address, Postal Zip Code

55113

City Area Code

612

Local Phone Number

331-6910

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $.01 per share

Trading Symbol

HWKN

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

Entity Central Index Key

0000046250

Amendment Flag

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration